Invention Grant
- Patent Title: Single chain variable fragment CD3 binding proteins
-
Application No.: US15704620Application Date: 2017-09-14
-
Publication No.: US10066016B2Publication Date: 2018-09-04
- Inventor: Robert B. Dubridge , Pui Seto , Richard J. Austin , Luke Evnin , Jeanmarie Guenot , Bryan D. Lemon
- Applicant: Harpoon Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: HARPOON THERAPEUTICS, INC.
- Current Assignee: HARPOON THERAPEUTICS, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Wilson, Sonsini, Goodrich & Rosati
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28

Abstract:
Disclosed herein are single chain variable fragment CD3 binding proteins with improved binding affinities, and robust aggregation profiles. Also described are multispecific binding proteins comprising a single chain variable fragment CD3 binding protein according to the instant disclosure. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are provided.
Public/Granted literature
- US20170369575A1 SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS Public/Granted day:2017-12-28
Information query